Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lauromacrogol 400 Foam Sclerotherapy for GSV Insufficiency
NCT00348764Phase 3Completed
- Sponsor
- CHU Grenoble Alpes
- Start
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of polidocanol in chronic venous insufficiency (CVI) (2 arms), sponsored by CHU Grenoble Alpes. Primary endpoint: Removal of truncular GSV incompetence evaluated by echo doppler at 6 months. Started Mar 2004; status: completed.
02
Drugs
polidocanol
03
Conditions
chronic venous insufficiency (CVI)
Beyond the preview
Go deeper on NCT00348764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00348764.